Unveiling the Significance of Peroxiredoxin 6 in Central Nervous System Disorders.

Prdx6 central nervous system glutathione peroxidase neurodegeneration neuroinflammation phospholipase A2

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
10 Apr 2024
Historique:
received: 01 03 2024
revised: 01 04 2024
accepted: 09 04 2024
medline: 27 4 2024
pubmed: 27 4 2024
entrez: 27 4 2024
Statut: epublish

Résumé

Peroxiredoxin 6 (Prdx6), a unique 1-Cys member of the peroxiredoxin family, exhibits peroxidase activity, phospholipase activity, and lysophosphatidylcholine acyltransferase (LPCAT) activity. Prdx6 has been known to be an important enzyme for the maintenance of lipid peroxidation repair, cellular metabolism, inflammatory signaling, and antioxidant damage. Growing research has demonstrated that the altered activity of this enzyme is linked with various pathological processes including central nervous system (CNS) disorders. This review discusses the distinctive structure, enzyme activity, and function of Prdx6 in different CNS disorders, as well as emphasizing the significance of Prdx6 in neurological disorders.

Identifiants

pubmed: 38671897
pii: antiox13040449
doi: 10.3390/antiox13040449
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Lijie Feng;Min Xue
ID : 81973337; 2023zhyx-C01; gxyqZD2020010; 2020xkjT002; 2023xkj001

Auteurs

Min Xue (M)

School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.

Xiaojie Huang (X)

School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Institute of Biopharmaceuticals, Anhui Medical University, Hefei 230032, China.

Tong Zhu (T)

School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Institute of Biopharmaceuticals, Anhui Medical University, Hefei 230032, China.

Lijun Zhang (L)

School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Institute of Biopharmaceuticals, Anhui Medical University, Hefei 230032, China.

Hao Yang (H)

School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Institute of Biopharmaceuticals, Anhui Medical University, Hefei 230032, China.

Yuxian Shen (Y)

School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Institute of Biopharmaceuticals, Anhui Medical University, Hefei 230032, China.

Lijie Feng (L)

School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Institute of Biopharmaceuticals, Anhui Medical University, Hefei 230032, China.

Classifications MeSH